IN2015MU03247A - - Google Patents

Info

Publication number
IN2015MU03247A
IN2015MU03247A IN3247MU2015A IN2015MU03247A IN 2015MU03247 A IN2015MU03247 A IN 2015MU03247A IN 3247MU2015 A IN3247MU2015 A IN 3247MU2015A IN 2015MU03247 A IN2015MU03247 A IN 2015MU03247A
Authority
IN
India
Prior art keywords
chitosan
stem cells
mesenchymal stem
umbilical cord
human umbilical
Prior art date
Application number
Inventor
H Pawar Dr S
Sneha Khumbar Dr Ms
Original Assignee
D Y Patil University Kolhapur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D Y Patil University Kolhapur filed Critical D Y Patil University Kolhapur
Priority to IN3247MU2015 priority Critical patent/IN2015MU03247A/en
Publication of IN2015MU03247A publication Critical patent/IN2015MU03247A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to preparation method of chitosan-aiginate scaffolds incorporated with mesenchymal stem cells.. The chitosan-alginate scaffolds are prepared by freeze-drying.method. The mesenchymal stem cells are isolated from human umbilical cord tissue which is discarded at birth. The human umbilical cord-derived MSCs (hU-MSCs) have shown faster proliferation rates and great therapeutic potential in various biomedical applications. .
IN3247MU2015 2015-08-25 2015-08-25 IN2015MU03247A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3247MU2015 IN2015MU03247A (en) 2015-08-25 2015-08-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3247MU2015 IN2015MU03247A (en) 2015-08-25 2015-08-25

Publications (1)

Publication Number Publication Date
IN2015MU03247A true IN2015MU03247A (en) 2015-09-18

Family

ID=54397304

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3247MU2015 IN2015MU03247A (en) 2015-08-25 2015-08-25

Country Status (1)

Country Link
IN (1) IN2015MU03247A (en)

Similar Documents

Publication Publication Date Title
JOP20200192A1 (en) Anti-tigit antibodies
MX2017013562A (en) Microbiome regulators and related uses thereof.
MX2020006117A (en) Targeted integration of nucleic acids.
EP3365037A4 (en) Derivation of human skin organoids from pluripotent stem cells
MX2021006581A (en) Bacteria engineered to treat diseases associated with hyperammonemia.
PH12017500402A1 (en) Anti-glucagon antibodies and uses thereof
PH12017500803A1 (en) Anti-pd-1 antibodies
EP3349783C0 (en) Compositions and methods relating to the treatment of diseases
MX2018002301A (en) Glycan compositions and uses thereof.
BR112017024384A2 (en) bacteria modified to reduce hyperphenylalaninemia
TW201613954A (en) Interleukin-10 fusion proteins and uses thereof
MX2021013837A (en) Combination immunotherapy approach for treatment of cancer.
EP3388512A4 (en) Method for separating and culturing mesenchymal stem cells from wharton's jelly tissue of umbilical cord
MX2017001279A (en) Flagellin compositons and uses.
EP3505629A4 (en) Sirna of human interleukin 6, recombinant expression car-t vector, and construction method and use thereof
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
MX2016012479A (en) Binding members to tnf alpha.
MX2016016756A (en) Stem cell therapy in endometrial pathologies.
MX2016013631A (en) Modified host cells and uses thereof.
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
MX2019005821A (en) Anti-gitr antigen-binding proteins and methods of use thereof.
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2019011613A (en) 1-amino-1-cyclopropanecaboxylic acid formulations.
EP3341079A4 (en) Methods and compositions relating to the diagnosis and treatment of cancer
KR101896803B9 (en) Method for increasing the rate of inducing differentiation of human pluripotent stem cells to mesenchymal stem cells and mesenchymal stem cells produced by thereof